INmune Bio
INMB
INMB
72 hedge funds and large institutions have $9.63M invested in INmune Bio in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $12.7M → $9.63M (-$3.09M)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Holders
72
Holding in Top 10
–
Calls
$1.19M
Puts
$991K
Top Buyers
| 1 | +$284K | |
| 2 | +$170K | |
| 3 | +$165K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$127K |
| 5 |
Jane Street
New York
|
+$103K |
Top Sellers
| 1 | -$608K | |
| 2 | -$412K | |
| 3 | -$311K | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$190K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$160K |
